Global Topical Anti-infective Drugs Market Growth (Status and Outlook) 2025-2031

According to this study, the global Topical Anti-infective Drugs market size will reach US$ 6099 million by 2031.

Topical anti-infective drugs are medications applied directly to the skin or mucous membranes to prevent or treat localized infections. These drugs include antibiotics, antifungals, antivirals, and antiseptics, and are formulated as creams, ointments, gels, lotions, or sprays. They are commonly used for treating skin infections, wounds, burns, fungal infections, and certain viral skin conditions.

United States market for Topical Anti-infective Drugs is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Topical Anti-infective Drugs is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Topical Anti-infective Drugs is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Topical Anti-infective Drugs players cover Bausch Health, LEO Pharma, SK-SF, Kaken Pharmaceutical, Haleon, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Topical Anti-infective Drugs Industry Forecast” looks at past sales and reviews total world Topical Anti-infective Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Topical Anti-infective Drugs sales for 2025 through 2031. With Topical Anti-infective Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Topical Anti-infective Drugs industry.

This Insight Report provides a comprehensive analysis of the global Topical Anti-infective Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Topical Anti-infective Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Topical Anti-infective Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Topical Anti-infective Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Topical Anti-infective Drugs.

This report presents a comprehensive overview, market shares, and growth opportunities of Topical Anti-infective Drugs market by product type, application, key players and key regions and countries.

Segmentation by Type:
Solution
Ointment
Gel
Other

Segmentation by Application:
Hospital
Retail Phamracy
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bausch Health
LEO Pharma
SK-SF
Kaken Pharmaceutical
Haleon
Bayer
J & J
STADA Arzneimittel
Galderma
Zhejiang Funo Pharmaceuticals
Jiangsu Fubang Pharmaceuticals
Shandong Jingwei Pharmaceuticals
Jiangsu Zhiyuan Pharmaceuticals
Liaoning Xingao Pharmaceuticals
Hubei Renfu
Almirall
Sandoz
Glenmark Pharmaceuticals
Sun Pharmaceutical
Teva

Please note: The report will take approximately 2 business days to prepare and deliver. Show more